Bioequivalence and Bioavailability Forum 00:53 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

PriyalAayushi
Junior

India,
2018-03-13 04:09

Posting: # 18524
Views: 851
 

 Profile comparison requirements [Regulatives / Guidelines]

Dear friends,

Is it must to have matching dissolution profile of all 3 registration batches with RLD for ANDA filing purpose?

If 2 batches have F2 50+ but one below 50, then what?

Please help.

Thanks
Helmut
Hero
avatar
Homepage
Vienna, Austria,
2018-03-13 13:36

@ PriyalAayushi
Posting: # 18529
Views: 685
 

 Homework

Hi Priyal,

» Is it must to have matching dissolution profile of all 3 registration batches with RLD for ANDA filing purpose?

Please do your homework first (see also this post #3).
Hint: In vivo equivalence always overrules in vitro similarity.

» If 2 batches have F2 50+ but one below 50, then what?

What do you think?

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes
jag009
Hero

NJ,
2018-03-15 21:45

@ PriyalAayushi
Posting: # 18557
Views: 553
 

 Profile comparison requirements

» If 2 batches have F2 50+ but one below 50, then what?

1) For FDA?
2) I assume F2 comparisons among all 3 batches are >50?

J
Back to the forum Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
18,697 posts in 3,982 threads, 1,238 registered users;
online 17 (0 registered, 17 guests [including 13 identified bots]).

Science should always be the basis
of regulatory requirements.    Joachim Röhmel

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed